Mdxhealth Adds Hereditary Prostate Cancer Genetic Test to Prostate Cancer Offering

Go back to Mdxhealth Adds Hereditary Prostate Cancer Genetic Test to Prostate Cancer Offering
(NASDAQ: MDXH) Delayed: 0.69 -0.03 (4.17%)
Previous Close $0.72    52 Week High
Open $0.72    52 Week Low
Day High $0.75    P/E N/A 
Day Low $0.69    EPS
Volume 173,328       

(NASDAQ: MDXH) Delayed: 0.69 -0.03 (4.17%)
Previous Close $0.72    52 Week High
Open $0.72    52 Week Low
Day High $0.75    P/E N/A 
Day Low $0.69    EPS
Volume 173,328